ENDRA Life Sciences Inc. (NDRA) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 39.72K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -39.72K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 2.13M | 1.62M | 1.37M | 1.3M | 1.47M | 4.3M | 1.51M | 2.23M | 2.78M | 1.46M | 3.13M | 2.99M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.4M | 1.11M | 938.59K | 920.03K | 940.6K | 3.66M | 714.57K | 1.51M | 1.74M | 878.43K | 1.5M | 1.59M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 776.41K | 508.14K | 432.11K | 381.06K | 528.68K | 637.96K | 794.44K | 716.37K | 1.04M | 579.35K | 1.63M | 1.4M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -39.72K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.17M | -1.62M | -1.37M | -1.3M | -1.47M | -4.3M | -1.51M | -2.23M | -2.78M | -1.46M | -3.13M | -2.99M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -47.95% | 62.25% | 9.17% | 41.68% | 47.16% | -194.75% | 51.77% | 25.5% | 5.4% | 56% | 8.43% | 16.16% |
| EBITDA | -2.13M | -1.58M | -1.33M | -1.27M | -1.42M | -4.25M | -1.46M | -2.18M | -2.72M | -1.4M | -3.06M | -2.92M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -49.89% | 62.77% | 8.5% | 41.84% | 47.75% | -204.35% | 52.43% | 25.36% | 5% | 56.97% | 8.93% | 16.9% |
| D&A (Non-Cash Add-back) | 39.72K | 39.53K | 39.39K | 32.79K | 45.58K | 46.36K | 54.01K | 50.12K | 55.68K | 61.25K | 70.45K | 72.71K |
| EBIT | -2.17M | -1.62M | -1.37M | -1.3M | -1.47M | -4.3M | -1.51M | -2.23M | -2.78M | -1.46M | -3.13M | -2.99M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | -7.32M | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 7.32M | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 862.32K | -1.55M | -225.26K | 75.18K | 432.95K | 147.74K | -845.08K | 1.7K | 4.84K | -1.76K | 28.23K | 437.43K |
| Pretax Income | -1.31M | -3.17M | -1.6M | -1.23M | -1.04M | -4.15M | -2.35M | -2.23M | -2.78M | -1.46M | -3.1M | -2.56M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -1.31M | -3.17M | -1.6M | -1.23M | -1.04M | -4.15M | -2.35M | -2.23M | -2.78M | -1.46M | -3.1M | -2.56M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -26.55% | 23.62% | 32.2% | 45.01% | 62.66% | -184.27% | 24.08% | 12.83% | 5.68% | 55.63% | 9.87% | 28.79% |
| Net Income (Continuing) | -1.31M | -3.17M | -1.6M | -1.23M | -1.04M | -4.15M | -2.35M | -2.23M | -2.78M | -1.46M | -3.1M | -2.56M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.09 | -3.26 | -2.10 | -1.71 | -1.86 | -7.73 | -2.10 | -1.31 | -1.63 | -0.85 | -1.82 | -1.50 |
| EPS Growth % | 41.4% | 57.83% | 0% | -30.53% | -14.11% | -809.41% | -15.38% | 12.67% | -6.54% | 49.7% | -1.68% | 19.79% |
| EPS (Basic) | -1.09 | -3.26 | -2.10 | -1.71 | -1.86 | -7.73 | -2.10 | -1.31 | -1.63 | -0.85 | -1.82 | -1.50 |
| Diluted Shares Outstanding | 1.2M | 787.02K | 761.22K | 717.11K | 557.58K | 536.91K | 1.12M | 1.71M | 1.71M | 1.71M | 1.71M | 1.71M |
| Basic Shares Outstanding | 1.2M | 787.02K | 761.22K | 717.11K | 557.58K | 536.91K | 1.12M | 1.71M | 1.71M | 1.71M | 1.71M | 1.71M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |